Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions
Year: 2017
Type: article
Abstract: Engagement of Fcγ-receptors triggers a range of downstream signalling events resulting in a diverse array of immune functions. As a result, blockade of Fc-mediated function is an important strategy for the control of several autoimmune and inflammatory conditions. We have generated a hexameric-Fc fusion protein (hexameric-Fc) and tested the consequences of multi-valent Fcγ-receptor engagement in in vitro and in vivo systems. In vitro engagement of hexameric-Fc with FcγRs showed complex binding interactions that altered with receptor density and triggered the internalisation and degradation of Fcγ-receptors. This caused a disruption of Fc-binding and phagocytosis. In vivo, in a mouse ITP model we observed a short half-life of hexameric-Fc but were nevertheless able to observe inhibition of platelet phagocytosis several days after hexameric-Fc dosing. In cynomolgus monkeys, we again observed a short half-life, but were able to demonstrate effective FcγR blockade. These findings demonstrate the ability of multi-valent Fc-based therapeutics to interfere with FcγR function and a potential mechanism through which they could have a sustained effect; the internalisation and degradation of FcγRs.
Source: Scientific Reports
Authors: O. S. Qureshi, T. F. Rowley, F. Junker, S. J. Peters, S. Crilly, J. Compson, A. Eddleston, H. Björkelund, K. Greenslade, M. Parkinson, N. L. Davies, R. Griffin, T. L. Pither, K. Cain, L. Christodoulou, L. Staelens, E. Ward, J. Tibbitts, A. Kiessling, B. Smith, F. R. Brennan, M. Malmqvist, F. Fallah-Arani, D. P. Humphreys
Institutions: UCB Pharma (United Kingdom), UCB Pharma (Belgium)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W2774794000
